Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Aventis Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 2
Rounds per year 0.20
Lead investments 0
Exits 2
Key employees 1

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Data Integration
  • Mineral
  • Industrial
Summary

In 2011 was created Aventis Capital, which is appeared as VC. The fund was located in Australia. The main office of represented VC is situated in the Sydney.

For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Amphora Discovery. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Data Integration.

The higher amount of exits for fund were in 2008. The high activity for fund was in 2004. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

Besides them, we counted 1 critical employee of this fund in our database.

The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Aventis Capital, startups are often financed by Venrock, ARCH Venture Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Venrock, Novartis Venture Fund. In the next rounds fund is usually obtained by Venrock, MPM Capital, Genavent.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Aventis Capital:
Typical Co-investors
Aventis Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Aventis Capital:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Azini Capital Partners England, London, United Kingdom
Crosstimbers Capital Group Houston, Texas, United States
Hult Alumni Angels -
Long View Technology Ventures Austin, Texas, United States
Participant Media Beverly Hills, California, United States
POC Clinical Research Japan, Tokyo
Stampede Ventures California, Los Angeles, United States
Thinkers Capital -
Tryin Capital China, Guangdong, Shenzhen
Xintongde Ziben -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Amphora Discovery

Biotechnology
Data Integration
Pharmaceutical
$20M08 Dec 2004 Durham, North Carolina, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Aventis Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 14M
Rounds per year 0.20
Peak activity year 2004
Lead investments 0
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Amphora Discovery

Biotechnology
Data Integration
Pharmaceutical
$20M08 Dec 2004 Durham, North Carolina, United States
Crunchbase icon

Content report

The following text will be sent to our editors: